Clinical Trials Logo
  1. Home
  2. Other
  3. NCT02492373

Topical Corticosteroids on the Incidence of Postinflammatory Hyperpigmentation After QsNdYAG Laser

Post Inflammatory Hyperpigmentation Clinical Trial

Official title:
Effect of Topical Corticosteroids on the Incidence of Postinflammatory Hyperpigmentation Following Q-switched Nd:YAG 532 nm Laser for Treatment of Facial Lentigines - A Pilot Study

Clinical Trial Summary

To investigate the benefit of the application of topical high potency steroid on the incidence of post inflammatory hyperpigmentation after laser treatment.

Clinical Trial Description

- The incidence of post inflammatory hyperpigmentation (PIH) after treating lentigines with Q-switched Nd:YAG laser was 78.3%.

- It has been found that the incidence of PIH decreased to 40% after applied topical high potency steroid 2 days after the laser treatment.

- By these anti-inflammatory and anti-PIH effects of the high potency steroid, the investigators aimed that the application of steroid 2 days before and 2 days after the laser treatment would be better reduction in the incidence of PIH after Q-switched Nd:YAG laser. ;

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Investigator), Primary Purpose: Treatment

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT02492373
Study type Interventional
Source Mahidol University
Contact
Status Completed
Phase N/A
Start date February 2015
Completion date May 2016
View Details
See also
  Status Clinical Trial Phase
Terminated NCT05327361 - LiftActiv B3 in Post Inflammatory Hyperpigmentation (PIHP) Phase 2
Not yet recruiting NCT03850119 - Nanofat on Wound Healing and Scar Formation N/A
Not yet recruiting NCT05883657 - Tolerance and Performance of Cyto-selective Difluoroethane-based Cryotherapy in the Treatment of Brown Spots (Solar and Senile Lentigines, Post-Inflammatory Hyperpigmentation) N/A
Completed NCT03402893 - The Use of Onexton in Moderate Acne Vulgaris for Patients With Skin of Color Phase 4
Completed NCT04704245 - Effectiveness of Epidermal Growth Factor-containing Ointment on the Solar Lentigines N/A
Completed NCT05704114 - Tazarotene 0.045% Lotion for Treating PIE and PIH in Subjects With Acne Phase 4
Not yet recruiting NCT03765021 - Tranexamic Acid vs Fractional CO2 Laser in Post-acne Hyperpigmentation N/A
Completed NCT01038869 - Efficacy and Safety Study of Finacea to Treat Acne Vulgaris and Post-Inflammatory Hyperpigmentation (PIH) Phase 4
Not yet recruiting NCT06361251 - Interventional, Monocentric, Double-blind Randomized Category 2b Study Evaluating the Evaluation of the Tolerance of Cyto-selective Difluoroethane-based Cryotherapy in the Treatment of Brown Spots (Solar and Senile Lentigines, Post -Inflammatory Hyperpigmentation (Pih)) on the Face N/A
Not yet recruiting NCT06305897 - Evaluation of the Tolerance (Main Objective) and Performance of Cyto-selective Difluoroethane-based Cryotherapy in the Treatment of Brown Spots (Solar and Senile Lentigines, Post-inflammatory Hyperpigmentation) on the Face N/A